Our compounds are not approved for human consumption, medical use, veterinary use, diagnostic purposes, or any form of therapeutic application
A 2022 study published in The Journal of Clinical Endocrinology & Metabolism found that patients with type 2 diabetes using GLP-1 medications reported lower levels of depression and anxiety symptoms (Lee et al., 2022)
For broader options, see our Medical Weight Loss Services
Corcoran J, Jones G
Starting solids does not have to be stressful
It was approved in 2021 for adults who are either living with obesity (having a body mass index of 30 or greater) or living with overweight (a BMI of 27 or greater) plus at least one qualifying health condition, such as high blood pressure, type 2 diabetes, or high cholesterol